MEDIA RELEASE No: TP26/079 Friday, 13 November 2026 Genetic Signatures Limited – Panel Receives Application The Panel has received an application from BCAL Diagnostics Limited (BCAL) in relation to the affairs of Genetic Signatures Limited (GSS). Details of the application, as submitted by the...
GSS - Panel Receives Application
Filed with ASX · · 3 pages · English
Release
BCAL Diagnostics Limited on 6ix
Earlier from BCAL Diagnostics
- Change of Director's Interest Notice
- Quarterly Activities/Appendix 4C Cash Flow Report
- BCAL Welcomes Dr John Melki's Appointment to GSS Board
- Results of Meeting
- AGM 2026 Presentation
Later from BCAL Diagnostics
- Application for quotation of securities - BDX
- Notification of cessation of securities - BDX
- BCAL Expands Breast Cancer Biomarker Program
- Notification regarding unquoted securities - BDX
- BCAL Position on GSS-MAP Merger
Follow BCAL Diagnostics into a list and get an email when it puts out news.
Follow BCAL Diagnostics